HEALTH RISK & SOCIETY

Caesarean or vaginarean epidemics ? Techno-birth, risk and obstetric practice in Turkey

The influence of parents’ information processing on childhood vaccine acceptance after a vaccine crisis in China

Raw milk is always risky: stabilising the danger of raw milk in Australian food safety regulation

The impact of technology on pregnancy and childbirth: creating and managing obstetrical risk in different cultural and socio-economic contexts

Birth models in and between Italy and Senegal: a cross-cultural inquiry on the risks related to childbirth and birth technologies

The biomedicalisation of reproductive ageing: reproductive citizenship and the gendering of fertility risk

What disasters can reveal about techno-medical birth: Japanese women’s stories of childbirth during the 11 March, 2011 earthquake

Buying reassurance: uptake of non-invasive prenatal testing among pregnant women of advanced maternal age in China

‘I can tell when you’re staring at my glass …’: self- or co-surveillance? Couples’ management of risks related to alcohol use during pregnancy

The costs of risk and fear: a qualitative study of risk conceptualisations in allied health resource allocation decision-making

Health risk perception and shale development in the UK and US

Health regulations and social experiences of ‘high-risk’ pregnancies among young working-class women in Brazil

Everyday strategies for handling food safety concerns: a qualitative study of distrust, contradictions, and helplessness among Taiwanese women

The construction and navigation of riskscapes in public health advice and mothers’ accounts of weaning

‘There’s a before and an after’: effects of a personal history of cancer on perception of cancer risks and adoption of behaviours

Why people remain inactive during a crisis: Interpreting and dealing with a crisis within a broader social context

Perceived colorectal cancer candidacy and the role of candidacy in colorectal cancer screening

Lifestyles are risky, too: the social construction of risk and empowerment in prescription drug direct-to-consumer advertisements